Search for other works by this author on: ...

Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.

Search for other works by this author on: ...

University of Nebraska Medical Center, Omaha, NE, ...

Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia.

Adding the PD-1 inhibitor pembrolizumab to chemoradiotherapy for high-risk, locally advanced cervical cancer significantly improves patients’ overall survival compared to treatment with CRT alone.

According to the phase IIIb/IV DESTINYBreast-12 Trial, the results of which were presented at the European Society for Medical Oncology 2024 Congress in Barcelona, Spain, and concurrently published, ...

Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to ...

Interested individuals should prepare and submit an application to Christine Battle, Publisher and Vice President, Scientific Publications, AACR via email ([email protected]) by Monday, ...

First Disclosures in Molecular Cancer Therapeutics present drugs for the first time in published literature, accompanied by pertinent translational investigations. Submissions are assessed based on ...